| Previous Close | 0.0006 |
| Open | 0.0006 |
| Bid | 0.0000 x 0 |
| Ask | 0.0000 x 0 |
| Day's Range | 0.0004 - 0.0007 |
| 52 Week Range | 0.0004 - 0.0014 |
| Volume | 24,551,763 |
| Avg. Volume | 39,773,873 |
| Market Cap | N/A |
| Beta | -16.34 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Marketwired•last month
Protext Pharma CEO Discusses South Africa Cannabis License
Protext Pharma, Inc. , a biotech company engaged in the development of pharmaceutical botanical medicines that are formulated with highly bioavailable plant extracts, today provided an update with regards ...
- Marketwired•3 months ago
Protext Mobility Completes Name Change to Protext Pharma and Provides Update on Medical Cannabis License
Protext Pharma, Inc. , a biotech company engaged in the development of pharmaceutical applications with highly bioavailable Phytofare® extracts, has announced today that its name change to Protext Pharma, ...
- Marketwired•4 months ago
Protext Mobility Signs Agreement With Leading Research Center, CIDP, to Conduct Diabetes Human Clinical Trial
Protext Mobility, Inc. , a biotech company engaged in the development of pharmaceutical applications with highly bioavailable Phytofare® extracts, announced today that it has signed an agreement with the ...
